Atlas Trials

A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain

Clinical trial NCT00973141 · TERMINATED

Trial details

NCT number
NCT00973141
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
OsteoarthritisOsteoarthritis, HipOsteoarthritis, KneePainArthralgiaJoint Pain
Start date
2009-09-16
Primary completion
2011-06-30
Enrollment
467

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.